ZKB BARRIER REVERSE CONVERTIBLE ON WORST OF - PROCTER & GAMBLE/PEPSICO/JOHNSON & JOHNSON Stock

Certificat

Z08XPZ

CH1303980028

Real-time Bid/Ask 09:09:53 2024-05-23 EDT
104.42 USD / 104.92 USD +0.25% Intraday chart for ZKB BARRIER REVERSE CONVERTIBLE ON WORST OF - PROCTER & GAMBLE/PEPSICO/JOHNSON & JOHNSON
Current month+1.99%
1 month+2.24%
Date Price Change
24-05-22 104.4 +0.29%
24-05-21 104.1 +0.04%
24-05-17 104.1 +0.11%
24-05-16 104 +0.11%
24-05-15 103.8 +0.11%

Delayed Quote Swiss Exchange

Last update May 22, 2024 at 11:20 am

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer ZKB
Z08XPZ
ISINCH1303980028
Date issued 2023-12-19
Strike 156.5 $
Maturity 2024-12-19 (210 Days)
Parity 0.16 : 1
Emission price 100 $
Emission volume N/A
Settlement both
Currency USD

Technical Indicators

Highest since issue 104.4 $
Lowest since issue 100.5 $
Spread 5 $
Spread %0.48%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
153.5 USD
Average target price
173 USD
Spread / Average Target
+12.70%
Consensus
  1. Stock Market
  2. Certificates
  3. Z08XPZ Certificat